Home/Filings/3/0001181431-11-008750
3//SEC Filing

KING PHARMACEUTICALS INC 3

Accession 0001181431-11-008750

CIK 0001047699operating

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 6:05 PM ET

Size

7.2 KB

Accession

0001181431-11-008750

Insider Transaction Report

Form 3
Period: 2011-01-31
PFIZER INC
10% Owner
Holdings
  • Common Stock, no par value

    (indirect: By Parker Tennessee Corp.)
    230,719,938
Holdings
  • Common Stock, no par value

    (indirect: By Parker Tennessee Corp.)
    230,719,938
Footnotes (2)
  • [F1]Reflects shares purchased by Parker Tennessee Corp. ("Purchaser"), a wholly-owned subsidiary of Pfizer Inc. ("Parent"), in a tender offer.
  • [F2]The shares are owned directly by Purchaser. The shares may also be deemed to be indirectly beneficially owned by Parent.

Issuer

KING PHARMACEUTICALS INC

CIK 0001047699

Entity typeoperating
IncorporatedTN

Related Parties

1
  • filerCIK 0001047699

Filing Metadata

Form type
3
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 6:05 PM ET
Size
7.2 KB